207 related articles for article (PubMed ID: 22474252)
1. Crossveinless 2 regulates bone morphogenetic protein 9 in human and mouse vascular endothelium.
Yao Y; Jumabay M; Ly A; Radparvar M; Wang AH; Abdmaulen R; Boström KI
Blood; 2012 May; 119(21):5037-47. PubMed ID: 22474252
[TBL] [Abstract][Full Text] [Related]
2. Regulation of bone morphogenetic protein-4 by matrix GLA protein in vascular endothelial cells involves activin-like kinase receptor 1.
Yao Y; Zebboudj AF; Shao E; Perez M; Boström K
J Biol Chem; 2006 Nov; 281(45):33921-30. PubMed ID: 16950789
[TBL] [Abstract][Full Text] [Related]
3. High-density lipoproteins affect endothelial BMP-signaling by modulating expression of the activin-like kinase receptor 1 and 2.
Yao Y; Shao ES; Jumabay M; Shahbazian A; Ji S; Boström KI
Arterioscler Thromb Vasc Biol; 2008 Dec; 28(12):2266-74. PubMed ID: 18948634
[TBL] [Abstract][Full Text] [Related]
4. Homeobox D3, A Novel Link Between Bone Morphogenetic Protein 9 and Transforming Growth Factor Beta 1 Signaling.
Wang L; Yao J; Yu T; Zhang D; Qiao X; Yao Z; Wu X; Zhang L; Boström KI; Yao Y
J Mol Biol; 2020 Mar; 432(7):2030-2041. PubMed ID: 32061928
[TBL] [Abstract][Full Text] [Related]
5. Bone morphogenetic protein 9 (BMP9) and BMP10 enhance tumor necrosis factor-α-induced monocyte recruitment to the vascular endothelium mainly via activin receptor-like kinase 2.
Mitrofan CG; Appleby SL; Nash GB; Mallat Z; Chilvers ER; Upton PD; Morrell NW
J Biol Chem; 2017 Aug; 292(33):13714-13726. PubMed ID: 28646109
[TBL] [Abstract][Full Text] [Related]
6. Activation of vascular bone morphogenetic protein signaling in diabetes mellitus.
Boström KI; Jumabay M; Matveyenko A; Nicholas SB; Yao Y
Circ Res; 2011 Feb; 108(4):446-57. PubMed ID: 21193740
[TBL] [Abstract][Full Text] [Related]
7. Expression of vascular endothelial growth factor is coordinately regulated by the activin-like kinase receptors 1 and 5 in endothelial cells.
Shao ES; Lin L; Yao Y; Boström KI
Blood; 2009 Sep; 114(10):2197-206. PubMed ID: 19506300
[TBL] [Abstract][Full Text] [Related]
8. BMP-9 signals via ALK1 and inhibits bFGF-induced endothelial cell proliferation and VEGF-stimulated angiogenesis.
Scharpfenecker M; van Dinther M; Liu Z; van Bezooijen RL; Zhao Q; Pukac L; Löwik CW; ten Dijke P
J Cell Sci; 2007 Mar; 120(Pt 6):964-72. PubMed ID: 17311849
[TBL] [Abstract][Full Text] [Related]
9. Matrix Gla protein deficiency causes arteriovenous malformations in mice.
Yao Y; Jumabay M; Wang A; Boström KI
J Clin Invest; 2011 Aug; 121(8):2993-3004. PubMed ID: 21765215
[TBL] [Abstract][Full Text] [Related]
10. Activin-like kinase receptor 1 (ALK1) in atherosclerotic lesions and vascular mesenchymal cells.
Yao Y; Zebboudj AF; Torres A; Shao E; Boström K
Cardiovasc Res; 2007 May; 74(2):279-89. PubMed ID: 17074310
[TBL] [Abstract][Full Text] [Related]
11. TGFbeta/BMP type I receptors ALK1 and ALK2 are essential for BMP9-induced osteogenic signaling in mesenchymal stem cells.
Luo J; Tang M; Huang J; He BC; Gao JL; Chen L; Zuo GW; Zhang W; Luo Q; Shi Q; Zhang BQ; Bi Y; Luo X; Jiang W; Su Y; Shen J; Kim SH; Huang E; Gao Y; Zhou JZ; Yang K; Luu HH; Pan X; Haydon RC; Deng ZL; He TC
J Biol Chem; 2010 Sep; 285(38):29588-98. PubMed ID: 20628059
[TBL] [Abstract][Full Text] [Related]
12. Anti-human activin receptor-like kinase 1 (ALK1) antibody attenuates bone morphogenetic protein 9 (BMP9)-induced ALK1 signaling and interferes with endothelial cell sprouting.
van Meeteren LA; Thorikay M; Bergqvist S; Pardali E; Stampino CG; Hu-Lowe D; Goumans MJ; ten Dijke P
J Biol Chem; 2012 May; 287(22):18551-61. PubMed ID: 22493445
[TBL] [Abstract][Full Text] [Related]
13. Tmem100, an ALK1 receptor signaling-dependent gene essential for arterial endothelium differentiation and vascular morphogenesis.
Somekawa S; Imagawa K; Hayashi H; Sakabe M; Ioka T; Sato GE; Inada K; Iwamoto T; Mori T; Uemura S; Nakagawa O; Saito Y
Proc Natl Acad Sci U S A; 2012 Jul; 109(30):12064-9. PubMed ID: 22783020
[TBL] [Abstract][Full Text] [Related]
14. Serum/glucocorticoid-regulated kinase 1 as a novel transcriptional target of bone morphogenetic protein-ALK1 receptor signaling in vascular endothelial cells.
Araki M; Hisamitsu T; Kinugasa-Katayama Y; Tanaka T; Harada Y; Nakao S; Hanada S; Ishii S; Fujita M; Kawamura T; Saito Y; Nishiyama K; Watanabe Y; Nakagawa O
Angiogenesis; 2018 May; 21(2):415-423. PubMed ID: 29478089
[TBL] [Abstract][Full Text] [Related]
15. BMP-9 regulates the osteoblastic differentiation and calcification of vascular smooth muscle cells through an ALK1 mediated pathway.
Zhu D; Mackenzie NC; Shanahan CM; Shroff RC; Farquharson C; MacRae VE
J Cell Mol Med; 2015 Jan; 19(1):165-74. PubMed ID: 25297851
[TBL] [Abstract][Full Text] [Related]
16. BMP9 (Bone Morphogenetic Protein-9)/Alk1 (Activin-Like Kinase Receptor Type I) Signaling Prevents Hyperglycemia-Induced Vascular Permeability.
Akla N; Viallard C; Popovic N; Lora Gil C; Sapieha P; Larrivée B
Arterioscler Thromb Vasc Biol; 2018 Aug; 38(8):1821-1836. PubMed ID: 29880487
[TBL] [Abstract][Full Text] [Related]
17. Alk2/ACVR1 and Alk3/BMPR1A Provide Essential Function for Bone Morphogenetic Protein-Induced Retinal Angiogenesis.
Lee HW; Chong DC; Ola R; Dunworth WP; Meadows S; Ka J; Kaartinen VM; Qyang Y; Cleaver O; Bautch VL; Eichmann A; Jin SW
Arterioscler Thromb Vasc Biol; 2017 Apr; 37(4):657-663. PubMed ID: 28232325
[TBL] [Abstract][Full Text] [Related]
18. Bone morphogenetic protein (BMP) and activin type II receptors balance BMP9 signals mediated by activin receptor-like kinase-1 in human pulmonary artery endothelial cells.
Upton PD; Davies RJ; Trembath RC; Morrell NW
J Biol Chem; 2009 Jun; 284(23):15794-804. PubMed ID: 19366699
[TBL] [Abstract][Full Text] [Related]
19. Bone morphogenetic proteins.
Chen D; Zhao M; Mundy GR
Growth Factors; 2004 Dec; 22(4):233-41. PubMed ID: 15621726
[TBL] [Abstract][Full Text] [Related]
20. BMP type I receptor ALK2 is required for angiotensin II-induced cardiac hypertrophy.
Shahid M; Spagnolli E; Ernande L; Thoonen R; Kolodziej SA; Leyton PA; Cheng J; Tainsh RE; Mayeur C; Rhee DK; Wu MX; Scherrer-Crosbie M; Buys ES; Zapol WM; Bloch KD; Bloch DB
Am J Physiol Heart Circ Physiol; 2016 Apr; 310(8):H984-94. PubMed ID: 26873969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
